Disposition of 12084 shares by Audhya Paul K. of Kalvista Pharmaceuticals subject to Rule 16b-3
| ETNHX Fund | USD 35.59 0.29 0.81% |
Slightly above 62% of Eventide Healthcare's investor base is looking to short. The analysis of overall sentiment of trading Eventide Healthcare Life mutual fund suggests that many investors are alarmed at this time. Eventide Healthcare's investing sentiment can be driven by a variety of factors including economic data, Eventide Healthcare's earnings reports, geopolitical events, and overall market trends.
Eventide |
Filed transaction by Kalvista Pharmaceuticals Officer: Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Eventide Healthcare Fundamental Analysis
We analyze Eventide Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eventide Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eventide Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Five Year Return
Five Year Return Comparative Analysis
Eventide Healthcare is currently under evaluation in five year return among similar funds. Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
Eventide Healthcare Life Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eventide Healthcare mutual fund to make a market-neutral strategy. Peer analysis of Eventide Healthcare could also be used in its relative valuation, which is a method of valuing Eventide Healthcare by comparing valuation metrics with similar companies.
Peers
Eventide Healthcare Related Equities
| ETGLX | Eventide Gilead | 0.06 |
| ||
| ETILX | Eventide Gilead | 0.07 |
| ||
| CPOAX | Morgan Stanley | 0.20 |
| ||
| BFOCX | Berkshire Focus | 0.29 |
| ||
| ETIHX | Eventide Healthcare | 0.79 |
|
Other Information on Investing in Eventide Mutual Fund
Eventide Healthcare financial ratios help investors to determine whether Eventide Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eventide with respect to the benefits of owning Eventide Healthcare security.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |